Barinthus Biotherapeutics plc. (BRNS) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $98.17M | -38.8% |
| 2024 | $160.33M | -25.3% |
| 2023 | $214.51M | -20.6% |
| 2022 | $270.20M | -3.7% |
| 2021 | $280.71M | +454.1% |
| 2020 | $50.67M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $98.17M | -38.8% |
| 2024 | $160.33M | -25.3% |
| 2023 | $214.51M | -20.6% |
| 2022 | $270.20M | -3.7% |
| 2021 | $280.71M | +454.1% |
| 2020 | $50.67M | — |